AEW-541

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAEW-541
Drug Alias NameNVP-AEW-541AEW-541NVP-AEW541-NXNVP-AEW541-NX7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I inhibitors
TargetsInsulin-like growth factor I
Therapy Area/IndicationsHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A